Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
63 studies found for:    burzynski
Show Display Options
Download search resultsDownload the search results for:
burzynski (63 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Unknown  Antineoplaston Therapy in Treating Patients With Residual or Recurrent Anaplastic Astrocytoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
2 Unknown  Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
3 Unknown  Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
4 Unknown  Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin
Condition: Carcinoma of Unknown Primary
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
5 Unknown  Antineoplaston Therapy in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
6 Completed Antineoplaston Therapy in Treating Patients With Stage IV Melanoma
Condition: Melanoma (Skin)
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
7 Terminated Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
8 Unknown  Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
9 Unknown  Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
10 Unknown  Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer
Condition: Lung Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
11 Terminated Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus
Condition: Esophageal Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
12 Unknown  Antineoplaston Therapy in Treating Children With Visual Pathway Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
13 Unknown  Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
14 Unknown  Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
15 Unknown  Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
16 Unknown  Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
17 Unknown  Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
18 Unknown  Antineoplaston Therapy in Treating Children With Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
19 Unknown  Antineoplaston Therapy in Treating Patients With Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
20 Unknown  Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
Condition: Adrenocortical Carcinoma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.